1. Home
  2. FWRD vs MYGN Comparison

FWRD vs MYGN Comparison

Compare FWRD & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$25.03

Market Cap

708.1M

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.95

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
MYGN
Founded
1981
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
708.1M
625.5M
IPO Year
1993
1995

Fundamental Metrics

Financial Performance
Metric
FWRD
MYGN
Price
$25.03
$6.95
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$33.67
$11.82
AVG Volume (30 Days)
567.3K
1.1M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,496,734,000.00
$825,300,000.00
Revenue This Year
$3.18
$0.10
Revenue Next Year
$4.39
$5.28
P/E Ratio
N/A
N/A
Revenue Growth
14.54
0.21
52 Week Low
$9.79
$3.76
52 Week High
$35.47
$15.47

Technical Indicators

Market Signals
Indicator
FWRD
MYGN
Relative Strength Index (RSI) 61.67 45.11
Support Level $25.31 $7.15
Resistance Level $26.70 $7.43
Average True Range (ATR) 1.05 0.30
MACD 0.15 -0.01
Stochastic Oscillator 74.00 3.81

Price Performance

Historical Comparison
FWRD
MYGN

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: